Articles filed under Health Crises
-
US regulators approve 2nd gene therapy for blood cancerOct 18, 2017 7:00 am - TRENTON, N.J. (AP) - U.S. regulators on Wednesday approved a second gene therapy for a blood cancer, a one-time, custom-made treatment for aggressive lymphoma in adults....
-
Kane County to spend $100,000 more on naloxone to fight overdosesOct 18, 2017 1:00 am - Kane County will spend another $100,000 to order more than 2,000 additional doses of naloxone, a drug used to save the lives of people overdosing on heroin and prescript...
-
Correction: Pain Gap storyOct 16, 2017 7:00 am - WASHINGTON (AP) - In a story Oct. 12 about the worldwide gap in pain relief medication, The Associated Press misspelled the last name of a Stanford University psychiatry...
-
US obesity problem is not budging, new data showsOct 13, 2017 7:00 am - NEW YORK (AP) - America's weight problem isn't getting any better, according to new government research. Overall, obesity figures stayed about the same: About 40 percent...
-
Puerto Rico hurricane may cause shortage of hospital IV bagsOct 13, 2017 7:00 am - A key U.S. maker of hospital products said it expects a temporary shortage of small saline bags because of the hurricane that hit Puerto Rico. The hurricane wiped out th...
-
The Latest: FDA advisers endorse gene therapy for blindnessOct 12, 2017 7:00 am - SILVER SPRING, Md. (AP) - The Latest on an FDA panel's discussion on a gene therapy treatment for blindness (all times local): 3:19 p.m. U.S. health advisers have endors...
-
Sweden won't prosecute Italian stem cell scientistOct 12, 2017 7:00 am - STOCKHOLM (AP) - Swedish prosecutors have abandoned an investigation against a disgraced Italian stem cell scientist suspected of involuntary manslaughter in connection ...
-
FDA advisers endorse gene therapy to treat form of blindnessOct 12, 2017 7:00 am - SILVER SPRING, Md. (AP) - A potentially groundbreaking treatment for a rare form of blindness moved one step closer to U.S. approval Thursday, as federal health advisers...
-
Merck scraps disappointing experimental cholesterol drugOct 11, 2017 7:00 am - TRENTON, N.J. (AP) - Merck has decided to abandon efforts to market a closely watched experimental cholesterol medicine after mediocre test results. Merck's decision Wed...
-
Correction: Genetic Frontiers-Blindness-Gene Therapy storyOct 10, 2017 7:00 am - In a story Oct. 9 about an experimental gene therapy for blindness, The Associated Press erroneously reported the deadline for a decision by the U.S. Food and Drug Admin...